1. Home
  2. ESGRO vs NVRO Comparison

ESGRO vs NVRO Comparison

Compare ESGRO & NVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESGRO
  • NVRO
  • Stock Information
  • Founded
  • ESGRO N/A
  • NVRO 2006
  • Country
  • ESGRO Bermuda
  • NVRO United States
  • Employees
  • ESGRO 805
  • NVRO N/A
  • Industry
  • ESGRO Property-Casualty Insurers
  • NVRO Medical/Dental Instruments
  • Sector
  • ESGRO Finance
  • NVRO Health Care
  • Exchange
  • ESGRO Nasdaq
  • NVRO Nasdaq
  • Market Cap
  • ESGRO N/A
  • NVRO 134.5M
  • IPO Year
  • ESGRO N/A
  • NVRO 2014
  • Fundamental
  • Price
  • ESGRO $20.49
  • NVRO $3.71
  • Analyst Decision
  • ESGRO
  • NVRO Hold
  • Analyst Count
  • ESGRO 0
  • NVRO 14
  • Target Price
  • ESGRO N/A
  • NVRO $7.97
  • AVG Volume (30 Days)
  • ESGRO N/A
  • NVRO 395.4K
  • Earning Date
  • ESGRO N/A
  • NVRO 02-19-2025
  • Dividend Yield
  • ESGRO N/A
  • NVRO N/A
  • EPS Growth
  • ESGRO N/A
  • NVRO N/A
  • EPS
  • ESGRO N/A
  • NVRO N/A
  • Revenue
  • ESGRO N/A
  • NVRO $419,146,000.00
  • Revenue This Year
  • ESGRO N/A
  • NVRO N/A
  • Revenue Next Year
  • ESGRO N/A
  • NVRO $0.65
  • P/E Ratio
  • ESGRO N/A
  • NVRO N/A
  • Revenue Growth
  • ESGRO N/A
  • NVRO N/A
  • 52 Week Low
  • ESGRO N/A
  • NVRO $3.52
  • 52 Week High
  • ESGRO N/A
  • NVRO $21.66
  • Technical
  • Relative Strength Index (RSI)
  • ESGRO 55.82
  • NVRO 38.60
  • Support Level
  • ESGRO $19.45
  • NVRO $3.60
  • Resistance Level
  • ESGRO $20.66
  • NVRO $3.90
  • Average True Range (ATR)
  • ESGRO 0.39
  • NVRO 0.29
  • MACD
  • ESGRO 0.05
  • NVRO 0.00
  • Stochastic Oscillator
  • ESGRO 85.95
  • NVRO 20.88

About ESGRO Enstar Group Limited Depository

Enstar Group Ltd is a (re)insurance group that offers capital release solutions through its network of group companies. It seeks to create value by managing (re)insurance companies and portfolios of (re)insurance and other liability businesses in run-off and striving to generate an attractive risk-adjusted return from its investment portfolio. Its operations are through four reportable segments: Run-off, Assumed Life, Investments, and Legacy Underwriting.

About NVRO Nevro Corp.

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.

Share on Social Networks: